The Overview of Interferon-CUSABIO
IJMS | Free Full-Text | Differential Effects of MS Therapeutics on B Cells—Implications for Their Use and Failure in AQP4-Positive NMOSD Patients | HTML
The innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis - Madsen - 2017 - Brain and Behavior - Wiley Online Library
Mechanism of Action of Interferon Beta in Treatment of Multiple Sclerosis - ScienceDirect
Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences
IFN-β pharmacogenomics in multiple sclerosis | Pharmacogenomics
Mechanism of Action of Interferon Beta in Treatment of Multiple Sclerosis - ScienceDirect
Mechanism of action of interferon beta-1b. | Download Scientific Diagram
Early interferon therapy may mitigate COVID-19 severity
Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies | The Pharmacogenomics Journal
Traumakine (FP-1201-lyo) | Faron
The mechanism of action of interferon-[beta] in relapsing multiple sclerosis - Document - Gale Academic OneFile
Interferon Beta Expression in MS | How Rebif® (interferon beta-1a) Works | HCPs
Interferon Mechanism of Action 18 | Download Scientific Diagram
Mechanism of Action of Interferon Beta in Treatment of Multiple Sclerosis - ScienceDirect
![PDF] Differential mechanisms of action of interferon-β and glatiramer acetate in MS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/355fb109ee78e40955efd42432726d3c118927e1/4-Figure3-1.png "PDF] Differential mechanisms of action of interferon-β and glatiramer acetate in MS | Semantic Scholar")
PDF] Differential mechanisms of action of interferon-β and glatiramer acetate in MS | Semantic Scholar
Interferon-β mechanisms of action in multiple sclerosis | Neurology
Frontiers | Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis | Immunology
Type I interferons in infectious disease | Nature Reviews Immunology
Interferon-β exacerbates Th17-mediated inflammatory disease: Trends in Immunology
PDF) THE EFFECTIVENESS OF INTERFERON BETA-1A IN MANAGEMENT OF MULTIPLE SCLEROSIS: A CASE REPORT
Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis - The Lancet Neurology
Type I and III interferon responses in SARS-CoV-2 infection | Experimental & Molecular Medicine
The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis | SpringerLink
Cells | Free Full-Text | Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side Effects | HTML
Mechanism of Action of Interferon Beta in Treatment of Multiple Sclerosis - ScienceDirect
